Market Research Logo

Influenza Diagnostics Market by Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) - Global Forecast to 202

Influenza Diagnostics Market by Test type (Traditional (Rapid Influenza Detection Test, Viral Culture, DFA, Serology Test), Molecular (RT-PCR, NASBA, LAMP, SAMBA)), End user (Hospital, Clinic, Reference lab, POC, Home Care Agency) - Global Forecast to 2021

The global influenza diagnostics market is expected to reach USD 767.4 million by 2021 from USD 508.0 million in 2016, at a CAGR of 8.6% from 2016 to 2021. On the basis of test type, the market is segmented into traditional and molecular diagnostic tests. The traditional diagnostic tests segment is further categorized into rapid influenza detection tests (RIDT), viral culture, direct fluorescent antibody (DFA) tests, and serological assays. In 2016, the RIDT segment is expected to account for the largest share of the traditional tests market owing to factors such as its user-friendliness, rapid generation of results, and easy interpretability. The molecular diagnostic tests segment is further divided into RT-PCR, nucleic acid sequence-based amplification (NASBA) tests, loop-mediated isothermal amplification-based assays (LAMP), and simple amplification-based assays (SAMBA). In 2016, the RT-PCR segment is expected to hold the largest share of the molecular diagnostic tests market due to its ability to detect and distinguish between influenza A and B viruses with high specificity.

On the basis of end user, the influenza diagnostics market is segmented into hospitals/clinical laboratories, reference laboratories, and other end users (point-of-care testing, home health agencies, and nursing homes). The hospitals/clinical laboratories end-user segment is expected to dominate the influenza diagnostics market in 2016. The large share of this segment can be attributed to the fact that most influenza disease diagnostic tests are carried out in hospitals and clinical laboratories, as these tests are highly complex in nature and require the use of specialized instruments.

On the basis of region, the market is segmented into North America, Europe, Asia-Pacific, and RoW. In 2016, the European region is expected to account for the largest share of the market due to the rapidly increasing prevalence of influenza and rise in aging population in Europe.

The increasing prevalence of influenza, growth in research funding for influenza diagnostics, and rising demand for rapid and effective disease diagnosis and treatment are the key factors driving the growth of the global influenza diagnostics market.

Research Coverage:
This report studies the influenza diagnostics market based on test type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, future prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.

The report provides insights on the following:
Product Development/Innovation: Product portfolios of the top players in the influenza diagnostics market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market

Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the influenza diagnostics market

Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various influenza diagnostic tests across geographies

Market Diversification: Exhaustive information about new products, recent developments, and investments in the influenza diagnostics market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
      • MARKETS COVERED
      • YEARS CONSIDERED IN THE REPORT
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • MARKET SIZE ESTIMATION
    • MARKET RANKING ANALYSIS
    • MARKET BREAKDOWN AND DATA TRIANGULATION
      • KEY DATA FROM SECONDARY SOURCES
      • KEY DATA FROM PRIMARY SOURCES
      • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
      • Table GLOBAL INFLUENZA DIAGNOSTICS MARKET SUMMARY
    • CONCLUSION
  • PREMIUM INSIGHTS
    • INFLUENZA DIAGNOSTICS: MARKET OVERVIEW
    • GEOGRAPHIC ANALYSIS: TRADITIONAL DIAGNOSTIC TESTS MARKET, BY TYPE (2016)
    • MOLECULAR DIAGNOSTIC TESTS MARKET SIZE, BY TYPE, 2016 VS. 2021 (USD MILLION)
    • LIFE CYCLE ANALYSIS, BY REGION (2016)
  • MARKET OVERVIEW
    • INTRODUCTION
    • DRIVERS
      • INCREASING PREVALENCE OF INFLUENZA
      • GROWTH IN RESEARCH FUNDING FOR INFLUENZA DIAGNOSTICS
      • RISING DEMAND FOR FASTER DIAGNOSIS AND CONTROL OF INFLUENZA
    • RESTRAINTS
      • VARIABILITY IN SENSITIVITY AND SPECIFICITY AMONG INFLUENZA DIAGNOSTIC TESTS
      • STRINGENT REGULATORY FRAMEWORK
      • RISING HEALTHCARE COSTS LIMITING THE USAGE OF NOVEL INFLUENZA DIAGNOSTIC TECHNIQUES
    • OPPORTUNITIES
      • ADVANCEMENTS IN GENOMIC AND PROTEOMIC TECHNOLOGIES
      • SIGNIFICANT GROWTH PROSPECTS IN DEVELOPING COUNTRIES
    • CHALLENGE
      • DEARTH OF SKILLED PERSONNEL TO HANDLE ADVANCED INFLUENZA DIAGNOSTIC TOOLS
    • REGULATORY FRAMEWORK
      • NORTH AMERICA
      • EUROPE
      • ASIA-PACIFIC
  • INFLUENZA DIAGNOSTICS MARKET, BY TEST TYPE
    • INTRODUCTION
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
    • TRADITIONAL DIAGNOSTIC TESTS
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
      • RAPID INFLUENZA DETECTION TESTS (RIDT)
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR RIDT, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR RIDT, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR RIDT, BY COUNTRY, 2014-2021 (USD MILLION)
      • VIRAL CULTURE
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR VIRAL CULTURE, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR VIRAL CULTURE, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR VIRAL CULTURE, BY COUNTRY, 2014-2021 (USD MILLION)
      • DIRECT FLUORESCENT ANTIBODY (DFA) TESTS
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR DFA TESTS, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR DFA TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR DFA TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
      • SEROLOGICAL ASSAYS
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR SEROLOGICAL ASSAYS, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR SEROLOGICAL ASSAYS, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR SEROLOGICAL ASSAYS, BY COUNTRY, 2014-2021 (USD MILLION)
    • MOLECULAR DIAGNOSTIC TESTS
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR TESTS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
      • RT-PCR
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR RT-PCR, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR RT-PCR, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR RT-PCR, BY COUNTRY, 2014-2021 (USD MILLION)
      • NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) TESTS
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR NASBA, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR NASBA, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR NASBA, BY COUNTRY, 2014-2021 (USD MILLION)
      • LOOP-MEDIATED ISOTHERMAL AMPLIFICATION-BASED ASSAYS (LAMP)
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR LAMP, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR LAMP, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR LAMP, BY COUNTRY, 2014-2021 (USD MILLION)
      • SIMPLE AMPLIFICATION-BASED ASSAYS (SAMBA)
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR SAMBA, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR SAMBA, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR SAMBA, BY COUNTRY, 2014-2021 (USD MILLION)
      • OTHER MOLECULAR DIAGNOSTIC TESTS
        • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR OTHER MOLECULAR DIAGNOSTIC TESTS, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR OTHER MOLECULAR DIAGNOSTIC TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR OTHER MOLECULAR DIAGNOSTIC TESTS, BY COUNTRY, 2014-2021 (USD MILLION)
  • INFLUENZA DIAGNOSTICS MARKET, BY END USER
    • INTRODUCTION
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • HOSPITALS/CLINICAL LABORATORIES
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR HOSPITALS/CLINICAL LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR HOSPITALS/CLINICAL LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR HOSPITALS/CLINICAL LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
    • REFERENCE LABORATORIES
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR REFERENCE LABORATORIES, BY COUNTRY, 2014-2021 (USD MILLION)
    • OTHER END USERS
      • Table INFLUENZA DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY REGION, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2014-2021 (USD MILLION)
  • INFLUENZA DIAGNOSTICS MARKET, BY REGION
    • INTRODUCTION
    • PEST ANALYSIS
      • POLITICAL FACTORS
      • ECONOMIC FACTORS
      • SOCIOCULTURAL FACTORS
      • TECHNOLOGICAL FACTORS
        • Table GLOBAL INFLUENZA DIAGNOSTICS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
        • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
        • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
    • EUROPE
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table EUROPE: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • GERMANY
        • Table GERMANY: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table GERMANY: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.K.
        • Table U.K.: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
        • Table U.K.: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.K.: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.K.: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD BILLION)
        • Table ROE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table ROE: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table NORTH AMERICA: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • U.S.
        • Table U.S.: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
        • Table U.S.: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S.: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table U.S.: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
      • CANADA
        • Table CANADA: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
        • Table CANADA: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • ASIA-PACIFIC
      • Table APAC: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD BILLION)
      • Table APAC: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table APAC: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table APAC: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
    • REST OF THE WORLD (ROW)
      • Table ROW: INFLUENZA DIAGNOSTICS MARKET SIZE, BY TEST TYPE, 2014-2021 (USD MILLION)
      • Table ROW: INFLUENZA DIAGNOSTICS MARKET SIZE FOR TRADITIONAL DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: INFLUENZA DIAGNOSTICS MARKET SIZE FOR MOLECULAR DIAGNOSTIC TESTS, BY TYPE, 2014-2021 (USD MILLION)
      • Table ROW: INFLUENZA DIAGNOSTICS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • LEADING PLAYERS IN THE INFLUENZA DIAGNOSTICS MARKET
      • Table RANK OF COMPANIES IN THE INFLUENZA DIAGNOSTICS MARKET, 2015
    • COMPETITIVE SITUATION AND TRENDS
      • PRODUCT LAUNCHES AND APPROVALS
        • Table PRODUCT LAUNCHES AND APPROVALS, 2014-2016
      • ACQUISITIONS
        • Table ACQUISITIONS, 2014-2016
      • EXPANSIONS
        • Table EXPANSIONS, 2014-2016
      • COLLABORATIONS AND AGREEMENTS
        • Table COLLABORATIONS AND AGREEMENTS, 2014-2016
  • COMPANY PROFILES
    • INTRODUCTION
    • F. HOFFMANN-LA ROCHE AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BECTON, DICKINSON AND COMPANY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • THERMO FISHER SCIENTIFIC INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • ALERE INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • DIASORIN S.P.A.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • QUIDEL CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • MERIDIAN BIOSCIENCE, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ANALYTIK JENA AG (A SUBSIDIARY OF ENDRESS+HAUSER AG)
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • LUMINEX CORPORATION
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • SA SCIENTIFIC, LTD.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
  • APPENDIX
    • INSIGHTS OF INDUSTRY EXPERTS
    • DISCUSSION GUIDE
    • OTHER DEVELOPMENTS
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report